These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33182594)

  • 21. Glycerophospholipid synthesis as a novel drug target against cancer.
    Dolce V; Cappello AR; Lappano R; Maggiolini M
    Curr Mol Pharmacol; 2011 Nov; 4(3):167-75. PubMed ID: 21222647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatty acid synthase drives the synthesis of phospholipids partitioning into detergent-resistant membrane microdomains.
    Swinnen JV; Van Veldhoven PP; Timmermans L; De Schrijver E; Brusselmans K; Vanderhoydonc F; Van de Sande T; Heemers H; Heyns W; Verhoeven G
    Biochem Biophys Res Commun; 2003 Mar; 302(4):898-903. PubMed ID: 12646257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.
    Menendez JA; Colomer R; Lupu R
    Med Hypotheses; 2005; 64(2):337-41. PubMed ID: 15607568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Pathways: Fatty Acid Synthase.
    Jones SF; Infante JR
    Clin Cancer Res; 2015 Dec; 21(24):5434-8. PubMed ID: 26519059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the perturbed metabolic pathways associating with prostate cancer cells and anticancer affects of obacunone.
    Xie J; Zhang AH; Qiu S; Zhang TL; Li XN; Yan GL; Sun H; Liu L; Wang XJ
    J Proteomics; 2019 Aug; 206():103447. PubMed ID: 31326558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatty Acid Synthase Inhibitor TVB-2640 Reduces Hepatic de Novo Lipogenesis in Males With Metabolic Abnormalities.
    Syed-Abdul MM; Parks EJ; Gaballah AH; Bingham K; Hammoud GM; Kemble G; Buckley D; McCulloch W; Manrique-Acevedo C
    Hepatology; 2020 Jul; 72(1):103-118. PubMed ID: 31630414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of Fatty Acid Synthesis Induces Apoptosis of Human Pancreatic Cancer Cells.
    Nishi K; Suzuki K; Sawamoto J; Tokizawa Y; Iwase Y; Yumita N; Ikeda T
    Anticancer Res; 2016 Sep; 36(9):4655-60. PubMed ID: 27630308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel antagonists of the thioesterase domain of human fatty acid synthase.
    Richardson RD; Smith JW
    Mol Cancer Ther; 2007 Jul; 6(7):2120-6. PubMed ID: 17620441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase.
    Yang YA; Han WF; Morin PJ; Chrest FJ; Pizer ES
    Exp Cell Res; 2002 Sep; 279(1):80-90. PubMed ID: 12213216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does endogenous fatty acid metabolism allow cancer cells to sense hypoxia and mediate hypoxic vasodilatation? Characterization of a novel molecular connection between fatty acid synthase (FAS) and hypoxia-inducible factor-1alpha (HIF-1alpha)-related expression of vascular endothelial growth factor (VEGF) in cancer cells overexpressing her-2/neu oncogene.
    Menendez JA; Vellon L; Oza BP; Lupu R
    J Cell Biochem; 2005 Apr; 94(5):857-63. PubMed ID: 15669079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of stearoyl-CoA desaturase expression is a frequent event in prostate carcinoma.
    Moore S; Knudsen B; True LD; Hawley S; Etzioni R; Wade C; Gifford D; Coleman I; Nelson PS
    Int J Cancer; 2005 Apr; 114(4):563-71. PubMed ID: 15609334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting fatty acid synthase-driven lipid rafts: a novel strategy to overcome trastuzumab resistance in breast cancer cells.
    Menendez JA; Vellon L; Lupu R
    Med Hypotheses; 2005; 64(5):997-1001. PubMed ID: 15780499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Structures and Bioactivities of Fatty Acid Synthase Inhibitors.
    Jiang H; Gan T; Zhang J; Ma Q; Liang Y; Zhao Y
    Curr Med Chem; 2019; 26(39):7081-7101. PubMed ID: 31538883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor effects of a drug combination targeting glycolysis, glutaminolysis and de novo synthesis of fatty acids.
    Cervantes-Madrid D; Dueñas-González A
    Oncol Rep; 2015 Sep; 34(3):1533-42. PubMed ID: 26134042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological inhibitors of Fatty Acid Synthase (FASN)--catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents?
    Lupu R; Menendez JA
    Curr Pharm Biotechnol; 2006 Dec; 7(6):483-93. PubMed ID: 17168665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?
    Menendez JA; Colomer R; Lupu R
    Med Hypotheses; 2005; 64(2):342-9. PubMed ID: 15607569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The potential role of fatty acids in prostate cancer determined by GC-MS analysis of formalin-fixed paraffin-embedded tissue samples.
    Buszewska-Forajta M; Raczak-Gutknecht J; Artymowicz M; Wesołowski W; Buczkowski K; Iżycka-Świeszewska E; Markuszewski MJ
    J Pharm Biomed Anal; 2021 Mar; 196():113907. PubMed ID: 33497978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: molecular mechanisms and therapeutic perspectives.
    Menendez JA
    Biochim Biophys Acta; 2010 Mar; 1801(3):381-91. PubMed ID: 19782152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the inhibitory activities of aceraceous plants on fatty acid synthase.
    Zhao WH; Gao C; Zhang YX; Tian WX
    J Enzyme Inhib Med Chem; 2007 Aug; 22(4):501-10. PubMed ID: 17847719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased fatty acid synthase as a therapeutic target in androgen-independent prostate cancer progression.
    Pizer ES; Pflug BR; Bova GS; Han WF; Udan MS; Nelson JB
    Prostate; 2001 May; 47(2):102-10. PubMed ID: 11340632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.